In advance-stage cancer, especially hepatocellular carcinoma [15], tumor-secreted TGF-β accelerates the differentiation of megakaryocytes and erythroid progenitors into splenic CD45−EPCs [16], which blocks the late stage of erythropoiesis. Here, TGFB1 is linked to neoplasm.